Immunologic Response to FluMist vs. Flucelvax
InfluenzaHuman1 moreThe purpose of this study is to evaluate immunologic response to different types of influenza vaccine among children/adolescents/young adults 4-21 years of age. This is a randomized controlled trial (RCT), that will assess immune response in about 440 participants (about 220 per vaccine arm) pre- and post-vaccination to FluMist (live attenuated influenza vaccine given by nasal administration) and Flucelvax (egg-free cell-culture inactivated influenza vaccine).
MGC Health COVID-19 & Flu A+B Home Multi Test Usability Study
COVID-19Influenza A1 moreThe purpose of this study is to evaluate the usability of the MGC Health COVID-19 & Flu A+B Home Multi Test in home use.
4 Pillars Toolkit for Adolescent Vaccination
Adolescent HPV VaccineAdolescent Influenza VaccineThe purpose of this study is to test whether or not the 4 Pillars Immunization Toolkit increases adolescent vaccination rates, particularly influenza and human papillomavirus (HPV) but also tetanus, diphtheria and pertussis (Tdap), and meningococcal conjugate (MCV) vaccination rates. The vaccines are all FDA licensed vaccines and to be used according to national guidelines. The investigators will conduct a randomized cluster trial of this toolkit in diverse primary care practices with electronic medical records (EMRs).
The Effect of Fact Versus Myth Messages on Receipt of Influenza Vaccination
Influenza VaccinationThe purpose of this study is to evaluate whether message design of educational materials increases vaccination rates among participants.
Infectivity, Replication & Immunogenicity of Live nH1N1 Vaccine
InfluenzaThe purpose of the study is to determine the amount of live virus that can be recovered from the nose of people who are vaccinated with the licensed live vaccine against H1N1, and to describe the immune response to vaccination.
Direct and Indirect Benefits of Influenza Vaccine Versus Placebo in Healthy Children
Influenza Virus InfectionWhile immunisation of school-age children against influenza is not recommended in Hong Kong, past experience in Japan and elsewhere suggests that immunisation of children may protect the wider community through its indirect transmission-limiting impact as well as the direct immunologic protection afforded vaccinated children themselves. We aim to assess whether vaccinating children against influenza protects vaccinees as well as their household contacts from infection.
Influenza Vaccination for Parents and Other Caregivers in the Pediatric Medical Home
InfluenzaWe hypothesize that when offered influenza vaccine at little or no cost, in a setting where the value of the vaccine is connected to one's high risk child, vaccination rates for parents will approach 90-95%, similar to rates obtained in the Neonatal Intensive Care Unit environment.
Safety and Immunogenicity of Two Doses of a Tetravalent Influenza Vaccine in Adults Aged 18 Years...
InfluenzaEvaluate the immune response and reactogenicity of H5N1 vaccination in adults aged 18 years and above (as part of a tetravalent vaccine)
Phase IV Trial to Collect Safety Data and Sera for Immunogenicity Testing in Healthy Children Given...
InfluenzaTo provide Centers for Biologic Evaluation and Research (CBER) with sera collected from healthy children receiving the 2007-2008 formulation of the inactivated, split-virion influenza vaccine Fluzone® for further study.
Study to Evaluate Impact of School-based Influenza Vaccination on School Populations
InfluenzaRates of confirmed influenza illness in vaccinated and non-vaccinated children will be compared between schools with and without vaccination programs. The investigators hypothesize that in addition to lowering rates of influenza in vaccinated children, raising vaccination rates by 30-40% through school-based vaccination programs will decrease incidence of influenza in non-vaccinated children attending those schools compared to non-vaccinated children in schools with low vaccination rates.